Bi-polar Disorder

Contents:

All Items (6)

NEWS RELEASE

Atypical Antipsychotics May Aid Symptoms for Some Off-Label Conditions, but Not Others — Sep 27, 2011

Evidence supports the effectiveness of some atypical antipsychotics in reducing symptoms of generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder and behavioral symptoms in elderly patients with dementia. There is insufficient evidence that the medications are effective for treating eating disorders, substance abuse and insomnia.

JOURNAL ARTICLE

Off-label Use of Atypical Antipsychotics: An Update — Sep 1, 2011

Antipsychotic medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia, bipolar disorder, and for some drugs, depression. We performed a systematic review on the efficacy and safety of atypical antipsychotic drugs for use in conditions lacking FDA approval.

JOURNAL ARTICLE

Racial and Ethnic Service Use Disparities Among Homeless Adults with Severe Mental Illnesses Receiving ACT — May 31, 2011

Case management of community interventions is intended to narrow racial and ethnic disparities, but this study of homeless individuals with severe mental illness found that it reduced disparities for blacks, but not for Latinos.

JOURNAL ARTICLE

Developing Medical Record-Based Performance Indicators to Measure the Quality of Mental Healthcare — Jan 14, 2011

This paper presents the methodology used to develop a comprehensive set of performance indicators in a national evaluation of the mental healthcare delivered by the Veterans Health Administration.

JOURNAL ARTICLE

Care for Veterans with Mental and Substance Use Disorders: Good Performance, but Room to Improve on Many Measures — Dec 31, 2010

The 15 % of veterans with mental health illness accounted for about one-third of total VA costs, mostly for non-mental health conditions. VA quality of care was generally better than care in private plans, but quality varied across VA regions.

JOURNAL ARTICLE

Trends in the Treatment of Bipolar Disorder By Outpatient Psychiatrists — Dec 31, 2001

Despite important advances in the range of mood stabilizers available, the pharmacological treatment of bipolar disorder continues to be an area with substantial opportunity for quality improvement.

My RAND ?

Saved Items

Recommended

View My Profile

Explore

Broader Topics

Similar Topics

Explore All Topics »